Department of Statistics, Federal University of Ouro Preto, Brazil.
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Stat Med. 2019 May 30;38(12):2126-2138. doi: 10.1002/sim.8097. Epub 2019 Jan 28.
Sequential analysis hypothesis testing is now an important tool for postmarket drug and vaccine safety surveillance. When the number of adverse events accruing in time is assumed to follow a Poisson distribution, and if the baseline Poisson rate is assessed only with uncertainty, the conditional maximized sequential probability ratio test, CMaxSPRT, is a formal solution. CMaxSPRT is based on comparing monitored data with historical matched data, and it was primarily developed under a flat signaling threshold. This paper demonstrates that CMaxSPRT can be performed under nonflat thresholds too. We pose the discussion in the light of the alpha spending approach. In addition, we offer a rule of thumb for establishing the best shape of the signaling threshold in the sense of minimizing expected time to signal and expected sample size. An example involving surveillance for adverse events after influenza vaccination is used to illustrate the method.
序贯分析假设检验现在是药品和疫苗上市后安全性监测的重要工具。当累积的不良事件数量随时间呈泊松分布,并且仅对基线泊松率进行不确定评估时,条件最大化序贯概率比检验(CMaxSPRT)是一种正式的解决方案。CMaxSPRT 基于比较监测数据与历史匹配数据,主要是在平坦信号阈值下开发的。本文证明了 CMaxSPRT 也可以在非平坦阈值下进行。我们根据 α 支出方法进行讨论。此外,我们还提供了一种经验法则,用于确定信号阈值的最佳形状,以最小化信号时间和样本量的期望。一个涉及流感疫苗接种后不良事件监测的示例用于说明该方法。